Video

Home Screening for Stroke Prevention: A Practical Assessment

Published: 01 Sep 2021

  • Views:

    Views Icon 3277
  • Likes:

    Heart Icon 1

In this symposium, held at the ESC Congress 2021, leading faculty discussed home screening for stroke prevention.

Atrial fibrillation (AFib) commonly occurs with hypertension, and is associated with a 5x greater risk of stroke.1 With effective treatment, the risk of stroke can be reduced. 2,3 However, up to 50% of AFib cases present with no subjective symptoms, making it unlikely to detect in an annual physical exam. 4 To reduce patients’ risk of stroke, medical guidelines recommend daily blood pressure measurements and screening with a single-lead electrocardiogram (ECG).5


Learning Objectives

  1. Recall the pathophysiology of hypertension in the development of AF and stroke
  2. Review the latest guidance on the use of home screening for AF
  3. Select individuals likely to benefit from home blood pressure and ECG monitoring
  4. Recognise the key features of one lead ECG that make it a practical screening tool for AF
     

Faculty 

Moderator 
Prof Jeroen Bax

Panel 
Prof Gerhard Hindricks
Assoc Prof Keitaro Senoo


References

1. Complications: atrial fibrillation. NHS. Reviewed April 24, 2018. Accessed November 2, 2020. https://www.nhs.uk/conditions/atrial-fibrillation/complications. 2. Gómez-Outes A, Lagunar-Ruíz J, Terleira-Fernández A, Calvo-Rojas G, Suárez-Gea ML, Vargas-Castrillón E. Causes of death in anticoagulated patients with atrial fibrillation. J Am Coll Cardiol. 2016;68(23):2508-2521.3. Hart RG, Pearce LA, Aguilar MI. Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Ann Intern Med. 2007;146(12):857-867. 4. Esato M, Chun Y, An Y, et al. Clinical impact of asymptomaticpresentation status in patients with paroxysmal  and sustained atrial fibrillation: the Fushimi AF Registry. Chest. 2017;152(6):1266-1275. 5. Hindricks G, Potpara T, Dagres N, et al. 2020 ESC Guidelines for thediagnosis and management of atrial fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2020;ehaa612. doi:10.10/93/eurheartj/ehaa612.

 

This symposium is sponsored by